MANCHESTER, UNITED KINGDOM, March 10, 2026 /EINPresswire.com/ -- Monument Therapeutics, a stratified medicine company, ...

The Delphi initiative—tied to the Greek oracle’s maxim “know thyself”—aims to support modular, chip-like sensors that could work in a variety of devices.

NKGen Biotech, Inc. (OTC: NKGN) ('NKGen” or the 'Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder strength in new dynamometry measurements Greater ...

World Schizophrenia Awareness Day, commemorated every May 24, underscores the global impact of this mental illness, affecting over 20 million individuals worldwide. This day highlights the critical ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Early prediction and identification of neurodegenerative diseases offers the best chance for prevention and treatment.

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

Amyloid PET has become a pivotal imaging biomarker for Alzheimer disease (AD), enabling in vivo detection and quantification of β-amyloid deposition. However, variability in quantitative measurements ...

The session Next-Generation Drug Development Enabled by Automation, Digitalization, and AI/ML is scheduled to take place at Pittcon 2026 in San Antonio, TX, on Monday, March 9, from 8:30 am–10:40 am ...

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.

AB Science says a newly identified blood biomarker may help assess masitinib activity in its ongoing Phase 3 ALS clinical trial.